Cite
HARVARD Citation
Bouzid, D. et al. (n.d.). Added value of rapid respiratory syndromic testing at point of care versus central laboratory testing: a controlled clinical trial. Journal of antimicrobial chemotherapy. pp. iii20-iii27. [Online].